Patents by Inventor Mark Taylor Keating

Mark Taylor Keating has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C5 Antigens and Uses Thereof
    Publication number: 20100166748
    Abstract: The present invention pertains to the use of a complement inhibitor in methods of treatment of ocular disorders and the use of a complement inhibitor in the manufacture of a medicament in the treatment of an ocular disorder.
    Type: Application
    Filed: March 19, 2008
    Publication date: July 1, 2010
    Inventors: Braydon Charles Guild, Mark Taylor Keating, Mariusz Milik, Dmitri Mikhailov, Michael Roguska, Igor Splawski, Kehao Zhao
  • USE OF ORGANIC COMPOUNDS
    Publication number: 20100047204
    Abstract: This invention relates to the use of compounds that disrupt IL-I receptor interaction for the treatment and/or prevention of ophthalmic diseases or disorders in mammals, particularly humans.
    Type: Application
    Filed: April 12, 2007
    Publication date: February 25, 2010
    Inventors: Dana Sue Yoo, Martin Neuner-Jehle, Baldo Scassellati-Sforzolini, Mark Taylor Keating, Olivier Sabri Markabi
  • Molecules and Methods for Modulating Complement Component
    Publication number: 20090175875
    Abstract: Compositions that bind to C3b epitopes and methods of using the compositions are described herein.
    Type: Application
    Filed: November 3, 2008
    Publication date: July 9, 2009
    Inventors: Bijan ETEMAD-GILBERTSON, Braydon Charles Guild, Mark Taylor Keating, Yong-In Kim, Lloyd B. Klickstein, Dmitri Mikhailov, Mariusz Milik, Michael Roguska, Igor Splawski, Kehao Zhao